About US
Contact us
-
FDA Approves Merck’s Ragwitek (Short Ragweed Pollen Allergen Extract) Sublingual TabletMerckhas annoouncedthatFDA has approved Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (12 Amb a 1-U). Ragwitek is an allergen extract indicated as immunotherapy for the2014/4/24
-
Valeant and Pershing Square announce merger proposal with AllerganCanada-based Valeant Pharmaceuticals and US-based Pershing Square Capital Management have disclosed details of their offer to purchase Botox-maker Allergan for more than $45bn. Valeant is proposing t2014/4/24
-
NICE limits approval for Ferring's prostate cancer drug FirmagonThe UK National Institute for Health and Clinical Excellence (NICE) has recommended Ferring Pharmaceuticals' Firmagon (degarelix) as an option for treating advanced hormone-dependent prostate cancer.2014/4/23
-
GSK and Genmab obtain FDA clearance for Arzerra as first-line treatment for CLLGlaxoSmithKline (GSK) and Genmab have obtained US Food and Drug Administration (FDA) approval for Arzerra (ofatumumab) as first-line treatment in combination with chlorambucil for patients with chroni2014/4/23
-
The price is right for patient-switching on Biogen's new hemophilia med AlprolixWith a pair of long-actinghemophiliameds on the way, Biogen Idec ($BIIB) appears poised to shake up the market for the bleeding disease. And though recently approvedAlprolixhas yet to launch, it has a2014/4/22
-
Full steam ahead for Copaxone copies as SCOTUS denies Teva's bid for delayLast week, generics makers asked the Supreme Court to let them launch their copies of Teva's Copaxone while it hears the Israeli company's appeal over the drug's patents. Now, they'll likely get that2014/4/22
-
Volasertib​, Boehringer Ingelheim'​s Investigat​ional Oncology Compound, is Granted Orphan Drug Designatio​n for Acute Myeloid Leukemia in the US and EUBoehringer Ingelheim Pharmaceuticals, Inc. has announced that FDA and European Commission (EC) have granted Orphan Drug Designation to volasertib for acute myeloid leukemia (AML). Volasertib is cur2014/4/21
-
Newly minted GlaxoSmithKline diabetes drug faces formidable foes in GLP-1 marketThere's a new kid on the diabetes block. GlaxoSmithKline's ($GSK) albiglutide, now dubbed Tanzeum for the U.S. market, nabbedFDAapproval Tuesday. Now, the drug will go up against a triad of other GL2014/4/21
-
BioAlliance Pharma and Topotarget join forces to create new orphan oncology companyBioAlliance Pharma and Topotarget have announced a merger agreement with an aim to create an orphan oncology company with increased scale and a highly complementary pipeline of late-stage products tar2014/4/18
-
FDA approves GSK's Tanzeum injection for type 2 diabetes treatmentThe US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) Tanzeum (albiglutide) subcutaneous injection to improve glycaemic control, along with diet and exercise, in adults with t2014/4/18